The BioPharm Brief: Prevention, Precision, and Progress

Jul 17, 03:03 PM
Headliner
Share
Subscribe

Prevention, precision, and progress take center stage as researchers report advances in pancreatic cancer prevention, uncover new insights into colorectal cancer immunotherapy, and introduce the first rapid-onset botulinum toxin approved in Europe.

Share
Subscribe
Next
The BioPharm Brief: Reduction, Reach, and Reinforcement
Top episodes
The BioPharm Brief: Early Design Risks, Oncology Signals, and a Biosimilars Power Move
by The BioPharm Brief
The BioPharm Brief: Cancer, Personalized
by The BioPharm Brief
The BioPharm Brief: What’s the Big Deal About Multispecific T-Cell Engagers in Cancer and Autoimmune Diseases?
by The BioPharm Brief